Role of hepatitis C virus in dual and triple hepatitis virus infection

Hepatology

Volumn 22, Issue 4 PART 1, 1995, Pages 1101-1108

  Liaw, Yun Fan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS B ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; SUPERINFECTION; VIRUS HEPATITIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMAN; SUPERINFECTION; SUPPORT, NON-U.S. GOV'T;

EID: 0029097382     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90615-0     Document Type: Article

References (84)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
3. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
4. Hepatitis C virus antibodies among risk groups in Spain
5. Prevalence of antibodies to hepatitis C virus in hemodialysis unit
6. Simultaneous acute infections with hepatitis non-A, non-B and B viruses
7. Natural history of chronic hepatitis B virus infection
8. Hepatitis delta virus infection of the liver: progress in virology, pathology, and diagnosis
9. Blood borne non-A, non-B hepatitis: Hepatitis C
10. Multiple hepatitis viruses in multiple attacks of acute viral hepatitis
11. Multiple hepatitis attacks in drug addicts
12. Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A, non-B
13. The occurrence of epidemic infectious hepatitis in chronic carriers of Australia antigen
14. Simultaneous infection with type A and B hepatitis viruses
15. Acute exacerbation of chronic type B hepatitis: comparison between HBeAg and antibody-positive patients
16. The etiology of acute hepatitis superimposed upon previously unrecognized HBsAg carriers
17. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees
18. Reduction in risk of hepatitis transmission by heat-treatment of a human factor VIII concentrate
19. Dialysis-associated hepatitis in Edinburgh; 1969–1978
20. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis
21. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection
22. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D
23. Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C
24. Hepatitis C virus infection is the major cause of severe liver disease in India
25. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis
26. Hepatitis viruses: changing patterns of human disease
27. Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infection
28. Non-A, non-B hepatitis in persistent carriers of hepatitis B virus
29. Acute hepatitis C virus superinfection followed by spontaneous HBsAg seroconversion and HBsAg elimination
30. A multicenter study of viral hepatitis in a United States hemophiliac population
31. Hepatitis C virus infection in chronic hepatitis B virus carriers
32. Epidemiology of hepatitis B and C in China
33. Diagnosis of hepatitis C virus-associated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chain reaction for the 5′noncoding region
34. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection
35. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients
36. Prevalence of hepatitis C virus related to liver disease in Korea
37. The role of hepatitis C virus in chronic hepatitis B virus infection
38. Viral hepatitis in Taiwan: status in the 1990s
39. Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections
40. Hepatitis C virus infection in patients with non-alcoholic chronic liver disease
41. Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases
42. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B
43. Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease
44. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B
45. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis
46. Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: the role of hepatitis B, C or D?
47. Hepatitis C virus in the etiology of chronic hepatitis and liver cirrhosis: possibility of mixed viral infections due to parenteral transmission
48. Diagnosis of chronic hepatitis C: Comparison of immunoassays and the polymerase chain reaction
49. Absence of precore stop mutant in chronic dual (B and C) and triple (B,C and D) hepatitis viruses infection
50. Dominant replication of either virus in dual infection with hepatitis viruses B and C
51. Hepatitis C virus infection in anti-HBe positive HBsAg carriers with chronic liver disease
52. Clinical and virological profiles in patients with multiple hepatitis virus infections
53. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis
54. Cellular immune responses in patients with dual infections of hepatitis B and C viruses: Dominant role of hepatitis C virus
55. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection
56. Role of hepatitis C and delta viruses in the termination of chronic HBsAg carrier state: a multivariate analysis in a longitudinal follow-up study
57. Viral replication in patients with multiple hepatitis virus infections
58. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma
59. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitation of the polymerase chain reaction
60. The role of hepatitis C virus in fulminant viral hepatitis in an endemic area of hepatitis A and B
61. Chronic hepatitis in multiple virus infection: histopathological evaluation
62. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B
63. Clinical outcome of hepatitis C virus antibody-positive renal allograft recipients
64. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan
65. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma
66. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis
67. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma
68. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma
69. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma
70. Persistence of hepatitis B and C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low endemic area
71. Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma
72. Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection
73. Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
74. Acute delta hepatitis in Greek parenteral drug abusers
75. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study
76. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice
77. Induction of tumor necrosis factor a production by human hepatocytes in chronic viral hepatitis
78. Cell cycle regulation of nuclear localization of hepatitis B virus core protein
79. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Huh-7 cells
80. Hepatitis C infection in patients with chronic hepatitis B: curiosity or cofactor?
81. Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: A randomized controlled trial
82. Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis
83. Coinfection with hepatitis B and C or B, C and D viruses results in severe chronic liver disease and responds poorly to interferon-a treatment
84. Reactivation of hepatitis B virus infection induced by interferon in HBsAg-positive, anti-HCV positive patients